ArticleCureus2025
Retinitis Pigmentosa in a Patient With a Homozygous Mutation in the RBP3 Gene: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinitis pigmentosa (RP) is a group of inherited retinal dystrophies characterized by progressive degeneration of the retina, leading to vision impairment. This report presents the case of a 56-year-old female patient with advanced RP caused by a homozygous genetic alteration affecting the RBP3 gene, specifically the c.802 A>T (p.Lys268*) variant. Our patient exhibited classic symptoms of night blindness, bilateral progressive vision loss, and a family history of similar symptoms. Ophthalmic evaluation, including optical coherence tomography (OCT), visual field testing, electroretinography (ERG), fluorescein angiography (FA), and genetic analysis, confirmed the diagnosis of advanced RP. Genetic testing identified the pathogenic homozygous mutation in the RBP3 gene, which, to our knowledge, has not been previously reported in the literature. This case highlights the importance of genetic testing in diagnosing retinal dystrophies, as well as the need for further studies to explore the full spectrum of RBP3-related retinal conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.